As of May 17
| +0.12 / +0.31%|
The 15 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 42.41, with a high estimate of 48.67 and a low estimate of 37.00. The median estimate represents a +7.48% increase from the last price of 39.46.
The current consensus among 18 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.